Bristol-Myers Squibb

Release Summary

Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute Announce Collaboration to Accelerate Immuno-Oncology Research

Bristol-Myers Squibb